Pharmacogenomics supports personalized medicine by translating
genome-based knowledge into clinical practice, offering enhanced benefit
for patients and health-care systems at large. Current routine practice
for diagnosing and treating patients is conducted by correlating
parameters such as age, gender and weight with risks and expected
treatment outcomes. In the new era of personalized medicine the
healthcare provider is equipped with improved ability to prevent,
diagnose, treat and predict outcomes on the basis of complex information
sources, including genetic and genomic data. Targeted therapy and
reliable prediction of expected outcomes offer patients access to better
healthcare management, by way of identifying the therapies effective for
the relevant patient group, avoiding prescription of unnecessary
treatment and reducing the likelihood of developing adverse drug
reactions.